On Sept. 19, a federal judge approved UnitedHealth Group’s acquisition of Change Healthcare over the concerns of the U.S. Department of Justice. The judge’s...
In an excerpt from his new book The Next Shift, University of Chicago historian Gabriel Winant explores how deindustrialization and the decline of the...
A new paper explores the resources consumed by the complicated billing process in health care and the process’ impact on patients’ access to care.
Health...
Although not the sole cause of high prescription drug costs, abusive practices that distort competition contribute to the problem. Too many companies exclude competition...
Chicago Booth alumnus and retired health care consultant David W. Ennis responds to ProMarket’s recent coverage on antitrust and the US health care system....
Harvard Business School professor Leemore Dafny lays out potential reforms to assist agencies in halting anticompetitive acquisitions and practices, and to preserve and promote...
Prescription drug shortages have become more common in recent years, interrupting usual medical care and increasing patient risk and system costs, but they are...